EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials

Makoto Kawashima, Tomoya Maeda, Kotaro Iwasaki, Masashi Takizawa, Noriaki Kaneda, Kenji Kabashima

Dermatology and Therapy · 2026-06 · 16 (6) · 3201-3214

DOI: 10.1007/s13555-026-01768-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology and Therapy, online erschienen am 15.05.2026. Verfasst von Makoto Kawashima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Maruho.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Atopic dermatitisIL-31Machine learningNemolizumabPost hoc analysis

Autor:innen und Institutionen

  • Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Kyoto R&D Center, Maruho Co., Ltd., Kyoto Research Park #5 Bldg., 93 Chudoji Awatacho, Shimogyo-ku, Kyoto, 600-8815, Japan. maeda_ewv@mii.maruho.co.jp.
  • Kyoto R&D Center, Maruho Co., Ltd., Kyoto Research Park #5 Bldg., 93 Chudoji Awatacho, Shimogyo-ku, Kyoto, 600-8815, Japan.
  • Medical Affairs Department, Maruho Co., Ltd., Osaka, Japan.
  • Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • A*STAR Skin Research Labs (A*SRL), Skin Research Institute of Singapore (SRIS), and Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Singapore, Singapore.

Förderung

  • Maruho

Zitieren

APA

Kawashima, M., Maeda, T., Iwasaki, K., Takizawa, M., Kaneda, N., & Kabashima, K. (2026). Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials. Dermatology and Therapy, 16(6), 3201-3214. https://doi.org/10.1007/s13555-026-01768-0

Vancouver

Kawashima M, Maeda T, Iwasaki K, Takizawa M, Kaneda N, Kabashima K. Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials. Dermatology and Therapy. 2026;16(6):3201-3214. doi:10.1007/s13555-026-01768-0

BibTeX
@article{Kawashima2026,
  author = {Kawashima, Makoto and Maeda, Tomoya and Iwasaki, Kotaro and Takizawa, Masashi and Kaneda, Noriaki and Kabashima, Kenji},
  title = {Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical Trials},
  journal = {Dermatology and Therapy},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {3201--3214},
  doi = {10.1007/s13555-026-01768-0}
}
Kostenlos starten →